Manipulation of the intestinal microbiome-a slow journey to primetime

Area of Science:

• Microbiology
• Gastroenterology
• Immunology

Background:

• The gut microbiota plays a crucial role in maintaining normal bodily functions.
• Dysbiosis, or alterations in the gut microbiota, is increasingly associated with various diseases.
• Fecal microbiota transplantation (FMT) is an ancient therapy involving the transfer of fecal matter to restore a healthy microbiome.

Purpose of the Study:

• To review the current literature on the microbiome's role in the pathogenesis and treatment of specific diseases.
• To highlight the efficacy of fecal microbiota transplantation (FMT) in managing various gastrointestinal and metabolic conditions.

Main Methods:

• Review of existing scientific literature on gut microbiome research.
• Analysis of studies investigating fecal microbiota transplantation (FMT) for different disease states.
• Synthesis of data on the microbiome's involvement in disease development and therapeutic interventions.

Main Results:

• Fecal microbiota transplantation (FMT) is highly effective for recurrent Clostridioides difficile infection (CDI).
• Emerging evidence suggests FMT efficacy in metabolic associated fatty liver disease (MAFLD), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD).

Conclusions:

• The gut microbiome is integral to health and disease.
• Fecal microbiota transplantation (FMT) represents a significant therapeutic option for CDI and holds potential for other complex diseases.
• Further research is warranted to fully elucidate the therapeutic applications of FMT in MAFLD, IBS, and IBD.